Kurzporträt
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Immunotherapies and Innovative Peptide-Based Vaccines
100,0
%
| 9 | 100,0 % | 3 | 100,0 % | -63.26% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 9 | 100,0 % | 3 | 100,0 % | -63.26% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Juan F. Vera
CEO | Chief Executive Officer | 44 | 17.10.18 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 01.11.19 |
Chief Tech/Sci/R&D Officer | 51 | 23.10.18 | |
Chief Administrative Officer | - | 01.09.15 | |
John Wilson
BRD | Director/Board Member | 64 | - |
Edmund Cheung
HRO | Human Resources Officer | - | 01.01.21 |
Nadia Agopyan
LAW | General Counsel | 62 | 15.08.19 |
General Counsel | 67 | 23.10.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Chairman | 63 | 17.10.18 | |
Steven Elms
BRD | Director/Board Member | 60 | 06.08.19 |
Katharine Knobil
BRD | Director/Board Member | 60 | 08.12.21 |
John Wilson
BRD | Director/Board Member | 64 | - |
Juan F. Vera
CEO | Chief Executive Officer | 44 | 17.10.18 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 8 902 897 | 7 819 659 ( 87,83 %) | 0 | 87,83 % |
Unternehmenskontakt
Marker Therapeutics, Inc.
4551 Kennedy Commerce Drive
77032, Houston
+713 400 6400
http://www.markertherapeutics.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+4.09% | 43.84 Mrd. | |
+46.28% | 41.25 Mrd. | |
+9.45% | 41.68 Mrd. | |
-10.92% | 27.04 Mrd. | |
+9.32% | 25.53 Mrd. | |
-24.87% | 18.18 Mrd. | |
+29.70% | 12.29 Mrd. | |
+1.28% | 12.29 Mrd. | |
+7.78% | 11.15 Mrd. |